Gastroesophageal reflux disease and sleep disorders: evidence for a causal link and therapeutic implications.
10.5056/jnm.2010.16.1.22 · doi-reference
Sleep and the metabolic syndrome.
10.1113/expphysiol.2006.033787 · doi-reference
Composition and concentration of bile acid reflux into the esophagus of patients with gastroesophageal reflux disease.
10.1016/s0039-6060(97)90327-5 · doi-reference
Bile acid metabolism and signaling.
10.1002/j.2040-4603.2013.tb00517.x · doi-reference
Diversity in the oesophageal phenotypic response to gastro-oesophageal reflux: immunological determinants.
10.1136/gut.50.4.451 · doi-reference
Novel insights on interactions between folate and lipid metabolism.
10.1002/biof.1154 · doi-reference
The renin-angiotensin system in the esophageal mucosa of healthy subjects and patients with reflux disease.
10.3109/00365521.2012.749510 · doi-reference
Interaction of oxidized low-density lipoprotein and the renin-angiotensin system in coronary artery disease.
10.1007/s11906-006-0010-2 · doi-reference
Metabolic syndrome is associated with gastroesophageal reflux disease based on a 24-hour ambulatory pH monitoring.
10.1111/j.1442-2050.2010.01118.x · doi-reference
Metabolic syndrome.
10.1016/j.ecl.2013.09.009 · doi-reference
Using multiple genetic variants as instrumental variables for modifiable risk factors.
10.1177/0962280210394459 · doi-reference
Bias in causal estimates from Mendelian randomization studies with weak instruments.
10.1002/sim.4197 · doi-reference
Estimation of effect size distribution from genome-wide association studies and implications for future discoveries.
10.1038/ng.610 · doi-reference
Gastroesophageal reflux disease influences blood pressure components, lipid profile and cardiovascular diseases: evidence from a Mendelian randomization study.
10.1515/jtim-2024-0017 · doi-reference
The MR-Base platform supports systematic causal inference across the human phenome.
10.7554/elife.34408 · doi-reference
Mendelian randomization.
10.1001/jama.2017.17219 · doi-reference
Strengthening the reporting of observational studies in epidemiology using Mendelian randomisation (STROBE-MR): explanation and elaboration.
10.1136/bmj.n2233 · doi-reference
Expansion of the gene ontology knowledgebase and resources.
10.1093/nar/gkw1108 · doi-reference
Mendelian randomization as an approach to assess causality using observational data.
10.1681/asn.2016010098 · doi-reference
Genome-wide cross-disease analyses highlight causality and shared biological pathways of type 2 diabetes with gastrointestinal disorders.
10.1038/s42003-024-06333-z · doi-reference
A Mendelian randomization study to assess the genetic liability of gastroesophageal reflux disease for cardiovascular diseases and risk factors.
10.1093/hmg/ddac162 · doi-reference
Adverse effects of statins - mechanisms and consequences.
10.2174/157488609789006949 · doi-reference
Hyperlipidemia.
10.1542/pir.2019-0053 · doi-reference
The biology and chemistry of hyperlipidemia.
10.1016/j.bmc.2007.04.031 · doi-reference
A review article on hyperlipidemia: types, treatments and new drug targets.
10.13005/bpj/504 · doi-reference
Research advances in current drugs targeting hyperlipidemia (review).
10.1186/s10020-025-01305-3 · doi-reference
Clinical practice. Gastroesophageal reflux disease.
10.1056/nejmcp0804684 · doi-reference
Clinical manifestations and complications of gastroesophageal reflux disease (GERD).
10.1111/j.1742-1241.2005.00370.x · doi-reference
Epidemiology of gastro-oesophageal reflux disease: a systematic review.
10.1136/gut.2004.051821 · doi-reference
Gastroesophageal reflux disease.
10.1016/j.pop.2017.07.001 · doi-reference
